The 7 linked references in paper К. Мukhin Yu., О. Pylaeva A., К. Мухин Ю., О. Пылаева Н. (2018) “Руфинамид (иновелон) в лечении синдрома Леннокса–Гасто (обзор литературы) // Rufinamide (inovelon) in the treatment of Lennox–gastaut syndrome (a review of literature)” / spz:neicon:rjdn:y:2018:i:2:p:20-33

  1. Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev 2017;39(6):464–9. PMID: 28202262. DOI: 10.1016/j.braindev.2017.01.006
  2. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 2015;56(7):1006–19. DOI: 10.1111/epi.13021. 55. Vendrame M., Lod
  3. Gooty V.D. et al. Experience with rufinamide in a pediatric population: a single center's experience. Pediatr Neurol 2010;43(3):155–8. PMID: 20691934. DOI: 10.1016/j.pediatrneurol.2010.04.003. 56. Verrott
  4. Efficacy of rufinamide in drug-resistant epilepsy: a meta-analysis. Pediatr Neurol 2011;44(5):347–9. PMID: 21481742. DOI: 10.1016/j.pediatrneuro
  5. Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007;9(4):353–412. PMID: 18077226. DOI: 10.1684/epd.2
  6. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol 2005;20(suppl 1):S1–56. PMID: 16615562. DOI: 10.1177/088307380502000101. 60. Wheless J.W., Conry J., Krauss
  7. Conflict of interest and financing. The article was published with the financial support of Eisai Co., Ltd. The authors bear full responsibility for the content of the article and editorial decisions. Статья поступил